90% of potential drugs fail, often because they lack the genetic evidence to prove they will work. Sequence Bio is on a mission to change that. By studying the inherited causes of disease, we aim to identify the right drug targets and predictors of disease and treatment response from the start—ensuring transformative medicines reach the people who need them.
Looking for a particular Sequence Bio employee's phone or email?
Sequence Bio Questions
The Sequence Bio annual revenue was $6 million in 2026.
Lynn Healey is the chief executive officer at Sequence Bio of Sequence Bio.
8 people are employed at Sequence Bio.
Sequence Bio is based in St. John S, Newfoundland and Labrador.
The NAICS codes for Sequence Bio are [541713, 541, 54171, 5417, 54].
The SIC codes for Sequence Bio are [873, 87].
Top Sequence Bio Employees
-
Lynn Healey
Chief executive officer at Sequence Bio at Sequence Bio
St. John's, NL, CA25+ -
Tom Barber
Chief Scientific Officer at Sequence Bio
Zionsville, IN, US25 -
Bari Ballew
Senior Director of Genomics at Sequence Bio
Washington, DC, US25+ -
Cameron Nugent
Lead Bioinformatician at Sequence Bio
Halifax Regional Municipality, NS, CA1 -
Diane Power
Director Research Coordination at Sequence Bio
St. John's, NL, CA2 -
Meg MacMillan
Bioinformatics Scientist at Sequence Bio
Toronto, ON, CA1
Related Companies
